Similar articles

• Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.

  Centers for Disease Control (CDC). Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1985 Jan 4;33(51-52):713-4. MMWR Morb Mortal Wkly Rep. 1985. PMID: 3917533 No abstract available.
• Fansidar for malaria prophylaxis.

  Kissane D. Kissane D. Aust Fam Physician. 1985 Aug;14(8):738. Aust Fam Physician. 1985. PMID: 3901990 No abstract available.
• Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.

  [No authors listed] [No authors listed] JAMA. 1985 May 3;253(17):2483-6. JAMA. 1985. PMID: 3157011 No abstract available.
• Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.

  Pearson RD, Hewlett EL. Pearson RD, et al. Ann Intern Med. 1987 May;106(5):714-8. doi: 10.7326/0003-4819-106-5-714. Ann Intern Med. 1987. PMID: 3551713 Review.
• The chemoprophylaxis of malaria.

  Chiodini PL. Chiodini PL. J Antimicrob Chemother. 1987 Sep;20(3):297-302. doi: 10.1093/jac/20.3.297. J Antimicrob Chemother. 1987. PMID: 3316145 Review. No abstract available.